Hilar Lymph Nodes of the Lung: Anatomy, Imaging, and Clinical Evaluation
Anatomical Location and Definition
Hilar lymph nodes are located at the lung hilum where the main bronchi, pulmonary arteries, and pulmonary veins enter and exit the lung parenchyma. 1
Right hilar nodes are positioned lateral to the A2 bronchus (79% of cases), medial or lateral to the interlobar pulmonary artery, and medial to the lower-lobe pulmonary artery 2
Left hilar nodes are found lateral to the A2 bronchus (49% of cases), medial to the interlobar pulmonary artery (100% of cases), medial to the lower-lobe pulmonary artery (60%), and in the angles of bifurcation of segmental arteries 2
Normal hilar lymph nodes appear triangular or linear and measure less than 3 mm in width on spiral CT, except around the left lower-lobe pulmonary artery where they may be slightly larger 2
In the TNM staging system, hilar nodes are classified as N1 nodes (stations 10-13: hilar, interlobar, lobar, segmental, and subsegmental) 1
Imaging Visualization
CT Imaging (Primary Modality)
CT with thin-section technique (1-3 mm slices) is the imaging method of choice for visualizing hilar lymph nodes. 1
Size criteria: Nodes with short-axis diameter >10 mm are considered abnormal, though the traditional threshold is 14 mm 1
Morphologic criteria significantly improve diagnostic accuracy beyond size alone 1
- Convex pleural interface between hilar structures and lung parenchyma indicates malignant involvement (95% specificity) 1
- Straight or concave pleural interface suggests normal lymph nodes (95% specificity) 1
- This morphologic criterion improves sensitivity from 50% to 87% and specificity from 80% to 83% 1
Multidetector CT with coronal reformations provides superior visualization of hilar anatomy and lymph node relationships 1
PET-CT Imaging
PET-CT is more accurate than CT alone for detecting hilar and mediastinal lymph node metastases, with median sensitivity of 80% and specificity of 88%. 1
PET relies on metabolic activity rather than anatomical size, allowing detection of malignancy in normal-sized nodes 1
Integrated PET-CT scanning is superior to visual correlation of separate PET and CT images for distinguishing hilar from mediastinal nodes 1
Limitation: PET is less sensitive for lymph nodes <7-10 mm in diameter due to spatial resolution constraints 1
MRI Imaging
MRI can visualize hilar lymph nodes approximately 1 cm in diameter that may be difficult to appreciate on CT. 3
MRI differentiates hilar masses from vasculature more easily than contrast-enhanced CT 3
Short inversion time inversion-recovery (STIR) sequences demonstrate high diagnostic accuracy (84-96%) for hilar node assessment 1
Diffusion-weighted imaging (DWI) shows promise with accuracy up to 98% for detecting nodal metastases 1
MRI is reserved for problem-solving when CT findings are equivocal, not for routine evaluation 1
Endobronchial Ultrasound (EBUS)
EBUS provides real-time visualization of hilar lymph nodes and enables ultrasound-guided transbronchial needle aspiration (TBNA). 4, 5
EBUS measurements of hilar nodes show weak correlation with CT measurements (intraclass correlation 0.44) 5
Benign nodes measure larger on CT than EBUS (14.1 mm vs 11.5 mm), while malignant nodes measure larger on EBUS than CT (17.3 mm vs 16.2 mm) 5
Critical finding: 24% of lymph nodes initially interpreted as normal-sized on axial CT contained malignant cells when sampled by EBUS-TBNA 5
Evaluation of Enlarged Hilar Lymph Nodes
Initial Assessment
When hilar lymph nodes are enlarged on CT or PET-CT, tissue confirmation is mandatory before denying potentially curative surgery. 1
Do not rely on size alone: Normal-sized nodes can harbor microscopic metastases, and enlarged nodes may be hyperplastic rather than neoplastic 1, 6
CT has limited sensitivity (41-67%) and specificity (79-86%) for determining nodal status based on size criteria alone 1
Diagnostic Algorithm for Hilar Node Enlargement
For peripheral tumors with enlarged hilar nodes on imaging, proceed with endosonography (EBUS/EUS) as the first-line invasive staging procedure. 1
If endosonography is positive: Confirms N1 disease; proceed with appropriate treatment planning 1
If endosonography is negative: Proceed to surgical staging (mediastinoscopy with complete nodal dissection) to avoid false-negative results 1
Combined EBUS/EUS approach achieves 93% sensitivity, superior to either modality alone (69% each) 1
For central tumors or tumors >3 cm, invasive staging should be considered even with normal-sized nodes on imaging. 1
Key Diagnostic Pitfalls
False-positive imaging results occur with benign reactive nodes showing follicular hyperplasia, which can appear enlarged but contain few macrophages 1, 6
False-negative imaging results occur when microscopic metastases exist within normal-sized lymph nodes 1
65% of lymph nodes initially interpreted as not enlarged on axial CT actually measured >10 mm on coronal CT and EBUS 5
Enlarged lymph nodes seen on CT must be sampled with biopsy to avoid overstaging before denying surgery 1
Tissue Sampling Recommendations
EBUS-TBNA is the preferred minimally invasive procedure for accessible hilar lymph nodes. 1, 4
EBUS-TBNA is safe with few complications and provides real-time guidance for needle placement 4
If EBUS-TBNA is negative in the presence of suspicious imaging findings, confirm with surgical staging (mediastinoscopy or video-assisted mediastinotomy) 1
For nodes in stations 5 and 6 (aortopulmonary window), EBUS cannot access these locations; left anterior mediastinotomy or VATS is required 1
Special Considerations
In patients with small peripheral tumors (T1a) and normal-sized, PET-negative hilar nodes, the risk of occult N1 disease is low but not zero 1
For adenocarcinomas with high FDG uptake and tumors >3 cm, invasive staging should be considered even with normal imaging 1
Post-treatment evaluation: CT remains the procedure of choice for routine follow-up; filling-in of previously patent ectatic bronchi may indicate recurrence 1